Specific dermatoses of pregnancy and their treatment

Dermatologic Therapy

Volumn 26, Issue 4, 2013, Pages 274-284

  Lehrhoff, Stephanie ^a   Pomeranz, Miriam Keltz ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atopic eruption of pregnancy (AEP); Intrahepatic cholestasis of pregnancy (ICP); Pemphigoid gestationis (PG); Pruritic urticarial papules and plaques of pregnancy (PUPPP); Pustular psoriasis of pregnancy (PPP)

Indexed keywords

ACICLOVIR; ANTIHISTAMINIC AGENT; AZATHIOPRINE; CALCIUM; CEPHALOSPORIN DERIVATIVE; CHLORPHENIRAMINE; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DAPSONE; DIPHENHYDRAMINE; EMOLLIENT AGENT; ERYTHROMYCIN; IMMUNOGLOBULIN G; INFLIXIMAB; MENTHOL; NICOTINAMIDE; PENICILLIN DERIVATIVE; PREDNISOLONE; PREDNISONE; RITUXIMAB; STEROID; TETRACYCLINE DERIVATIVE; TUMOR NECROSIS FACTOR INHIBITOR; URSODEOXYCHOLIC ACID;

ADD ON THERAPY; ARTICLE; ATOPIC ERUPTION OF PREGNANCY; CLINICAL FEATURE; DIARRHEA; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; INTRAHEPATIC CHOLESTASIS; INTRAHEPATIC CHOLESTASIS OF PREGNANCY; LOW DRUG DOSE; PAPULAR URTICARIA; PEMPHIGOID GESTATIONIS; PREGNANCY; PRURITIC FOLLICULITIS OF PREGNANCY; PRURITIC URTICARIAL PAPULE AND PLAQUE OF PREGNANCY; PUERPERAL DISORDER; PUSTULAR PSORIASIS; PUSTULAR PSORIASIS OF PREGNANCY; RASH; SINGLE DRUG DOSE; SKIN DISEASE; SKIN PRURITUS; TOPICAL TREATMENT;

ATOPIC ERUPTION OF PREGNANCY (AEP); INTRAHEPATIC CHOLESTASIS OF PREGNANCY (ICP); PEMPHIGOID GESTATIONIS (PG); PRURITIC URTICARIAL PAPULES AND PLAQUES OF PREGNANCY (PUPPP); PUSTULAR PSORIASIS OF PREGNANCY (PPP);

CHOLESTASIS, INTRAHEPATIC; FEMALE; HUMANS; PEMPHIGOID GESTATIONIS; PREGNANCY; PREGNANCY COMPLICATIONS; PRURITUS; PSORIASIS; SKIN DISEASES; SKIN DISEASES, VESICULOBULLOUS; TERMINOLOGY AS TOPIC; URTICARIA;

EID: 84885369186     PISSN: 13960296     EISSN: 15298019     Source Type: Journal    
DOI: 10.1111/dth.12078     Document Type: Article

References (86)

1. Roth MM. Pregnancy dermatoses. Am J Clin Dermatol 2011: 12 (1): 25-41.
2. Holmes RC, Black MM. A comparative study of toxic erythema of pregnancy and herpes gestationis. Br J Dermatol 1982: 106: 499-510.
3. Holmes RC, Black MM. The specific dermatoses of pregnancy. J Am Acad Dermatol 1983: 8: 405-412.
4. Shornick JK. Dermatoses of pregnancy. Semin Cutan Med Surg 1998: 17 (3): 172-181.
5. Ambros-Rudolph CM, Müllegger RR, Vaughn-Jones SA, Kerl H, Black MM. The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two center study on 505 pregnant patients. J Am Acad Dermatol 2006: 54: 395-404.
6. Bellman B, Berman B. Skin diseases seriously affecting fetal outcome and maternal health. In: Harahap K, Wallach RC, eds. Skin changes and diseases in pregnancy. New York: Marcel Dekker, Inc, 1996: 129.
7. Charles-Holmes R. Skin diseases specifically associated with pregnancy. In: Harahap K, Wallach RC, eds. Skin changes and diseases in pregnancy. New York: Marcel Dekker, Inc, 1996: 55.
8. Chang SE, Kim HH, Choi JH, Sung KJ, Moon KC, Koh JK. Impetigo herpetiformis followed by generalized pustular psoriasis: more evidence of same disease entity. Int J Dermatol 2003: 42: 754-755.
9. Lawley TJ, Hertz KC, Wade TR, Ackerman AB, Katz SI. Pruritic urticarial papules and plaques of pregnancy. JAMA 1979: 241 (16): 1696-1699.
10. Holmes RC. Polymorphic eruption of pregnancy. Semin Dermatol 1989: 8: 18-22.
11. Roger D, Vaillant L, Fignon A, et al. Specific pruritic dermatoses of pregnancy: a prospective study of 3192 women. Arch Dermatol 1994: 130: 734-739.
12. Rudolf CM, Al Fares S, Vaughan-Jones SA, Mullegger RR, Kerl H, Black MM. Polymorphic eruption of pregnancy: clinicopathology and potential trigger factors in 181 patients. Br J Dermatol 2006: 154: 54-60.
13. Alcalay J, Ingber A, Sandbank M. Unusual histopathological findings in polymorphic eruption of pregnancy (PUPPP). Z Hautkr 1987: 62: 879-881.
14. Aronson IK, Bond S, Fiedler VC, Vomvouras S, Gruber D, Ruiz C. Pruritic urticarial papules and plaques of pregnancy: clinical and immunopathologic observations in 57 patients. J Am Acad Dermatol 1999: 39: 933-939.
15. Kroumpouzos G, Cohen LM. Specific dermatoses of pregnancy: an evidence-based systematic review. Am J Obstet Gynecol 2003: 188: 1083-1092.
16. Ohel I, Levy A, Silberstein T, Holcberg G, Sheiner E. Pregnancy outcome of patients with pruritic urticarial papules and plaques of pregnancy. J Matern Fetal Neonatal Med 2006: 19 (5): 305-308.
17. Vaughan Jones SA, Hern S, Nelson-Piercy C, Seed PT, Black MM. A prospective study of 200 women with dermatoses of pregnancy correlating clinical findings with hormonal and immunopathological profiles. Br J Dermatol 1999: 141 (1): 71-81.
18. Beltrani VP, Beltrani VS. Pruritic urticarial papules and plaques of pregnancy: a severe case requiring early delivery for relief of symptoms. J Am Acad Dermatol 1992: 26 (1): 266-267.
19. Ambros-Rudolph CM. Dermatoses of pregnancy - clues to diagnosis, fetal risk and therapy. Ann Dermatol 2011: 23 (3): 265-275.
20. Kroumpouzos G, Cohen LM. Dermatoses of pregnancy. J Am Acad Dermatol 2001: 45 (10): 1-19.
21. Karen JK, Pomeranz MK. Skin changes and diseases in pregnancy. In: Wolff K, Goldsmith LA, Katz SI, et al., eds. Fitzpatrick's dermatology in general medicine, Vol. 1, 7th ed. New York: McGraw Hill Medical, 2007: 955-962.
22. Purohit DM, Ellison RC, Zierler S, Miettinen OS, Nadas AS. Risk factors for retrolental fibroplasia: experience with 3,025 premature infants. Pediatrics 1985: 76 (3): 339-344.
23. Reed J, George S. Pruritic folliculitis of pregnancy treated with narrowband (TL-O1) ultraviolet B phototherapy [letter]. Br J Dermatol 1999: 141: 177-179.
24. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk, 8th ed. Philadelphia: LippincotWilliams &Wilkins, 2008.
25. Gabbe SG. Drug therapy in autoimmune disease. Clin Obstet Gynecol 1987: 26: 635-641.
26. Frey FJ, Escher G, Frey BM. Pharmacology of 11betahydroxysteroid dehydrogenase. Steroids 1994: 59: 74-79.
27. Koutroulis I, Papoutsis J, Kroumpouzos G. Atopic dermatitis in pregnancy: current status and shallenges. Obstet Gynecol Surv 2011: 66 (10): 654-663.
28. Weatherhead S, Robson SC, Reynolds NJ. Eczema in pregnancy. BMJ 2007: 335: 152-154.
29. Latta RA, Baker DA. Treatment of recurrent eczema herpeticum in pregnancy with acyclovir. Infect Dis Obstet Gynecol 1996: 4: 239-242.
30. Yancey KB. Herpes gestationis. Dermatol Clin 1990: 8: 727- 734.
31. Lynch FW, Albrecht RJ. Hormonal factors in herpes gestationis. Arch Dermatol 1966: 93: 446-447.
32. Hönigsmann H, Stingl G, Holubar K, Wolff K. Herpes gestationis: fine ultrastructural pattern of immunoglobulin deposits in the skin in vivo. J Invest Dermatol 1976: 66: 389-392.
33. Lawley TJ, Stingl G, Katz SI. Fetal and maternal risk factors in herpes gestationis. Arch Dermatol 1978: 114 (4): 552-555.
34. Engineer L, Bhol K, Ahmed R. Pemphigoid gestationis: a review. Am J Obstet Gynecol 2000: 183: 483-491.
35. Kelly SE, Cerio R, Bhogal BS, Black MM. The distribution of IgG subclasses in pemphigoid gestationis: PG factor is an IgG1 autoantibody. J Invest Dermatol 1989: 92: 695-698.
36. Barnadas MA, Rubiales MV, Gonzalez MJ, et al. Enzymelinked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis. Int JDermatol 2008: 47: 1245-1249.
37. Powell AM, Sakuma-Oyama Y, Oyama N, et al.Usefulness of BP180 NC16a enzyme-linked immunosorbent assay in the serodiagnosis of pemphigoid gestationis and in differentiating between pemphigoid gestationis and pruritic urticarial papules and plaques of pregnancy. ArchDermatol 2005: 141: 705-710.
38. Amato L, Mei S, Gallerani MS, Fabbri P. A case of chronic herpes gestationis: persistent disease or conversion to bullous pemphigoid? J Am Acad Dermatol 2003: 49: 302-307.
39. Shornick JK, Black MM. Fetal risks in herpes gestationis. J Am Acad Dermatol 1992: 26: 63-68.
40. Chi CC, Wang SH, Charles-Holmes R. Pemphigoid gestationis: early onset and blister formation are associated with adverse pregnancy outcomes. Br J Dermatol 2009: 160: 1222-1228.
41. Shornick JK, Black MM. Secondary autoimmune disease in herpes gestationis (pemphigoid gestationis). J Am Acad Dermatol 1992: 26 (4): 563-566.
42. Hern S, Harmon K, Bhogal BS, Black MM. A severe persistent case of pemphigoid gestationis treated with intravenous immunoglobulins and cyclosporine. Clin Exp Dermatol 1998: 23: 185-188.
43. Kreuter A, Harati A, Breuckmann F, Appelhans C, Altmeyer P. Intravenous immune globulin in the treatment of persistent pemphigoid gestationis. J Am Acad Dermatol 2004: 51: 1027-1028.
44. Rodrigues Cdos S, Filipe P, Solana Mdel M, Soares de Almeida L, Cirne de Castro J, Gomes MM. Persistent herpes gestation is treated with high-dose intravenous immunoglobulin. Acta DermVenereol 2007: 87 (2): 184-186.
45. Doiron P, Pratt M. Antepartum intravenous immunoglobulin therapy in refractory pemphigoid gestationis: case report and literature review. J Cutan Med Surg 2010: 14: 189-192.
46. Amato L, Coronella G, Berti S, Gallerani I, Moretti S, Fabbri P. Successful treatment with doxycycline and nicotinamide of two cases of persistent pemphigoid gestationis. J Dermatolog Treat 2002: 13: 143-146.
47. Loo WJ, Dean D,Wojnarowska F. A severe persistent case of recurrent pemphigoid gestationis successfully treated with minocycline and nicotinamide. Clin Exp Dermatol 2001: 26: 726-727.
48. Castle SP, Mather-Mondrey M, Bennion S, David-Bajar K, Huff C. Chronic herpes gestationis and antiphospholipid antibody syndrome successfully treated with cyclophosphamide. J Am Acad Dermatol 1996: 34: 333-336.
49. Cianchini G, Masini C, Lupi F, et al. Severe persistent pemphigoid gestationis: long-term remission with Rituximab. Br J Dermatol 2007: 157: 388-389.
50. Lammert F, Marschall HU, Matern S. Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management. J Hepatol 2000: 33: 1012-1021.
51. Ropponen A, Sund R, Riikonen S, Ylikorkala O, Aittomäki K. Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study. Hepatology 2006: 43: 723-728.
52. Rioseco AJ, Ivankovic MB, Manzur A, et al. Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 1994: 170: 890-895.
53. Brites D, Rodriguez CM, Oliveira N, Cardoso M, Graça LM. Correction of maternal serum bile acid profile during ursodeoxycholic acid therapy in cholestasis of pregnancy. J Hepatol 1998: 28: 91-98.
54. Carter J. Serum bile acids in normal pregnancy. Br J Obstet Gynaecol 1991: 98: 540-543.
55. Glantz A, Marschall HU, Mattson LA. Intrahepatic cholestasis of pregnancy: relationships between bile acid levels and fetal complication rates. Hepatology 2004: 40: 467-474.
56. Locatelli A, Roncaglia N, Arreghini A, Bellini P, Vergani P, Ghidini A. Hepatitis C virus infection is associated with a higher incidence of cholestasis of pregnancy. Br J Obstet Gynaecol 1999: 106 (5): 498-500.
57. Glasinovic JC, Valdivieso V, Covarrubias C, Marinovic I, Miguel JF, Nervi F. Pregnancy and gallstones. In: Reyes HB, Leuschner U, Arias IM, eds. Pregnancy, sex hormones and the liver. Dordrecht: Kluwer, 1996: 267-281.
58. Reid R, Ivey KJ, Rencoret RH, Storey B. Fetal complications of obstetric cholestasis. Br Med J 1976: 1: 870-872.
59. Fisk NM, Storey GN. Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 1988: 95: 1137-1143.
60. Laatikainen T, Tulenheimo A. Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet 1984: 22: 91-94.
61. Shaw D, Frohlich J, Wittman BA, Willms M. A prospective study of 18 patients with cholestasis of pregnancy. Am J Obstet Gynecol 1982: 142: v621-v625.
62. Zimmermann P, Koskinen J, Vaalamo P, Ranta T. Doppler umbilical artery velocimetry in pregnancies complicated by intrahepatic cholestasis. J Perinat Med 1991: 19: 351-355.
63. Chappell LC, Gurung V, Seed PT, et al.Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomized clinical trial. BMJ 2012: 344: e3799.
64. Ambros-Rudolph CM, Glatz M, Trauner M, Kerl H, Müllegger RR. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from Central Europe. Arch Dermatol 2007: 143: 757-762.
65. Brites D, Rodrigues CM. Elevated levels of bile acids in colostrum of patients with cholestasis of pregnancy are decreased following ursodeoxycholic acid therapy. J Hepatol 1998: 29: 743-745.
66. Davies MH, da Silva RC, Jones SR, Weaver JB, Elias E. Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut 1995: 37: 580-584.
67. Floreani A, Paternoster D, Grella V, Sacco S, Gangemi M, Chiaramonte M. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy. Br J Obstet Gynaecol 1994: 101: 64-65.
68. Palma J, Reyes H, Ribalta J, et al. Effects of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy. Hepatology 1992: 15: 1043-1047.
69. Mazzella G, Rizzo N, Salzetta A, Lampieri R, Bovicelli L, Roda E. Management of intrahepatic cholestasis in pregnancy. Lancet 1991: 338: 1594-1595.
70. Laatikainen T. Effect of cholestyramine and phenobarbital on pruritus and serum bile acid levels in cholestasis of pregnancy. Am J Obstet Gynecol 1978: 132: 501-506.
71. Geenes V, Williamson C. Intrahepatic cholestasis of pregnancy. World J Gastroenterol 2009: 15: 2049-2066.
72. Mays JK. The active management of intrahepatic cholestasis of pregnancy. Curr Opin Obstet Gynecol 2010: 22: 100-103.
73. VonHebra F. Ueber einzelne, wahrend der schwangerschaft am wochenbette und bei urinalkrankheiten der frauzen zu beobachtende hautkrankheiten. Wien Med Wochenschr 1872: 22: 1197-1202.
74. Green M, Bragg J, Rosenman KS, Pomeranz MK. Pustular psoriasis of pregnancy in a patient whose dermatosis showed features of acute generalized exanthematous pustulosis. Int J Dermatol 2009: 48: 299-303.
75. Lotem M, Katzenelson V, Rotem A, Hod M, Sandbank M. Impetigo herpetiformis: a variant of pustular psoriasis or a separate entity? J AmAcad Dermatol 1989: 20: 338-341.
76. Finch TM, Tan CY. Pustular psoriasis exacerbated by pregnancy and controlled by cyclosporin A. Br J Dermatol 2000: 142: 582-584.
77. Breier-Maly J, Ortel B, Breier F, Schmidt JB, Hönigsmann H. Generalized pustular psoriasis of pregnancy (impetigo herpetiformis). Dermatology 1999: 198: 61-64.
78. Sasseville D, Wilkinson RD, Schnader JY. Dermatoses of pregnancy. Int J Dermatol 1981: 20 (4): 223-241.
79. Puig L, Barco D, Alomar A. Treatment of psoriasis with anti- TNF drugs during pregnancy: case report and review of the literature. Dermatology 2010: 220 (1): 71-76.
80. Oumeish OY, Farraj SE, Bataineh AS. Some aspects of impetigo herpetiformis. Arch Dermatol 1982: 118: 103-105.
81. Finch TM, Tan CM. Pustular psoriasis exacerbated by pregnancy and controlled by cyclosporine A. Br JDermatol 2000: 142: 582-584.
82. Valdés R, Núñez T, Pedraza D,MuñozH. Recurrent impetigo herpetiformis: successfully managed with cyclosporine. Report of one case [in Spanish]. Rev Med Chil 2005: 133: 1071-1074.
83. Imai N, Watanabe R, Fujiwara H, Ito M, Nakamura A. Successful treatment of impetigo herpetiformis with oral cyclosporine during pregnancy. Arch Dermatol 2002: 138 (1): 128-129.
84. Robinson A, Van Voorhees AS, Hsu S, et al. Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol 2012: 67: 279-288.
85. Gaughan WJ, Moritz MJ, Radomski JS, Burke JF Jr, Armenti VT. National Transplantation Pregnancy Registry: report on outcomes of cyclosporine-treated female kidney transplant recipients with an interval from transplantation to pregnancy of greater than five years. Am J Kidney Dis 1996: 28: 266-269.
86. Umezawa Y, Ozawa A, Kawasima T, et al. Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity. Arch Dermatol Res 2003: 295 (Suppl.): S43-S54.